ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ADASUVE
Mood disorders
Psychosis
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

ADASUVE Rx

Generic Name and Formulations:
Loxapine 10mg; powder for oral inhalation.

Company:
Alexza Pharmaceuticals

Therapeutic Use:

Indications for ADASUVE:

Acute treatment of agitation associated with bipolar I disorder in adults. Limitations of use: must be administered only in an enrolled healthcare facility.

Adult:

10mg by oral inhalation using a single-use inhaler. Administer only a single dose within a 24 hour period. Prior to administration, screen for current diagnosis or history of asthma, COPD, other lung diseases, and examine for respiratory signs. Monitor for signs/symptoms of bronchospasm and perform a physical exam at least every 15 mins for at least one hour after administration.

Children:

Not established.

Contraindications:

Current diagnosis or history of asthma, COPD, or other lung disease associated with bronchospasm. Acute respiratory signs/symptoms (eg, wheezing). Concomitant drugs to treat airways disease (eg, asthma, COPD). History of bronchospasm after Adasuve treatment. Amoxapine sensitivity.

Warnings/Precautions:

Risk of bronchospasm. Administer only by a healthcare personnel in facility that has immediate access to manage acute bronchospasm. Increased mortality in elderly patients with dementia-related psychosis (not approved use). Monitor for neuroleptic malignant syndrome. Cardio- or cerebrovascular disease. Conditions that predispose to hypotension (eg, dehydration, hypovolemia, or concomitant antihypertensive drugs). Perform fall risk assessments when initiating and recurrently on long-term therapy. History of seizures. Neonates: risk of extrapyramidal and/or withdrawal symptoms post delivery (due to exposure during 3rd-trimester of pregnancy). Pregnancy (Cat.C). Nursing mothers: not recommended.

Interactions:

Additive effects with concomitant other anticholinergics (eg, antiparkinson drugs) or other CNS depressants (eg, alcohol, opioids, benzodiazepines, tricyclic antidepressants, general anesthetics, phenothiazines, sedative/hypnotics, muscle relaxants); consider reducing dose of these drugs.

Pharmacological Class:

Dibenzoxazepine.

Adverse Reactions:

Dysgeusia, sedation, throat irritation; hypotension, syncope, lowered seizure threshold, anticholinergics effects (eg, glaucoma, urinary retention).

Note:

Available only through a restricted program under Adasuve REMS. Call (888) 970-7367 or visit www.adasuverems.com to enroll.

REMS:

YES

Generic Availability:

NO

How Supplied:

Single-use, disposable inhaler—5

Indications for ADASUVE:

Acute treatment of agitation associated with schizophrenia in adults. Limitations of use: must be administered only in an enrolled healthcare facility.

Adult:

10mg by oral inhalation using a single-use inhaler. Administer only a single dose within a 24 hour period. Prior to administration, screen for current diagnosis or history of asthma, COPD, other lung diseases, and examine for respiratory signs. Monitor for signs/symptoms of bronchospasm and perform a physical exam at least every 15 mins for at least one hour after administration.

Children:

Not established.

Contraindications:

Current diagnosis or history of asthma, COPD, or other lung disease associated with bronchospasm. Acute respiratory signs/symptoms (eg, wheezing). Concomitant drugs to treat airways disease (eg, asthma, COPD). History of bronchospasm after Adasuve treatment. Amoxapine sensitivity.

Warnings/Precautions:

Risk of bronchospasm. Administer only by a healthcare personnel in facility that has immediate access to manage acute bronchospasm. Increased mortality in elderly patients with dementia-related psychosis (not approved use). Monitor for neuroleptic malignant syndrome. Cardio- or cerebrovascular disease. Conditions that predispose to hypotension (eg, dehydration, hypovolemia, or concomitant antihypertensive drugs). Perform fall risk assessments when initiating and recurrently on long-term therapy. History of seizures. Neonates: risk of extrapyramidal and/or withdrawal symptoms post delivery (due to exposure during 3rd-trimester of pregnancy). Pregnancy (Cat.C). Nursing mothers: not recommended.

Interactions:

Additive effects with concomitant other anticholinergics (eg, antiparkinson drugs) or other CNS depressants (eg, alcohol, opioids, benzodiazepines, tricyclic antidepressants, general anesthetics, phenothiazines, sedative/hypnotics, muscle relaxants); consider reducing dose of these drugs.

Pharmacological Class:

Dibenzoxazepine.

Adverse Reactions:

Dysgeusia, sedation, throat irritation; hypotension, syncope, lowered seizure threshold, anticholinergics effects (eg, glaucoma, urinary retention).

Note:

Available only through a restricted program under Adasuve REMS. Call (888) 970-7367 or visit www.adasuverems.com to enroll.

REMS:

YES

Generic Availability:

NO

How Supplied:

Single-use, disposable inhaler—5

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs